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http://dx.doi.org/10.1016/j.jpurol.20Abstract Objective: The 45,X/46,XY and 45,X/47,XYY group of patients includes some of
those previously diagnosed with ‘mixed gonadal dysgenesis’. Our aim was to establish the clin-
ical and gonadal spectrum, and early surgical management, of patients with chromosomal
mosaicism presenting with genital anomalies.
Patients and methods: We performed a retrospective review of patients with 45,X/46,XY or
45,X/47,XYY mosaicism presenting with genital ambiguity between 1988 and 2009. At least
one gonadal biopsy or gonadectomy specimen was available for each patient. Gonadal
histology was re-evaluated by a paediatric pathologist.
Results: Of 31 patients with 45,X/46,XY (nZ 28) or 45,X/47,XYY (nZ 3) mosaicism and genital
anomalies, 19 (61%) were raised male. Histology of 46 gonads was available from patients who
had undergone a gonadectomy or gonadal biopsy, at a median age of 9.5 months. 18 gonads
were palpable at presentation, including 5 (28%) histologically unremarkable testes, 2 streak
gonads, and 1 dysgenetic gonad with distinct areas of testicular and ovarian stroma but no
oocytes. All intra-abdominal gonads were found to be dysgenetic testes (of which 2 were noted
to have pre-malignant changes) or streaks, apart from 1 histologically unremarkable testis. 15
(48%) patients had other anomalies, most commonly cardiac and renal; 4 (13%) had a Turner
phenotype.aediatric Urologist, Department of Paediatric Surgery, Chelsea and Westminster Hospital, 369 Fulham
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140 M.K. Farrugia et al.Table 1 Gonadal types and hist
Gonad
‘Unremarkable’ testis
Ovary
Dysgenetic/dysplastic gonad
Streak gonad
OvotestisConclusion: The anatomy and gonadal histology of 45,X/46,XY and 45,X/47,XYY individuals
with genital ambiguity do not conform to a set pattern, and hence management of each
patient should be individualized according to detailed anatomical and histological assessment.
ª 2012 Journal of Pediatric Urology Company. Published by Elsevier Ltd.
Open access under CC BY license.Introduction
The 2006 consensus statement on the management of
disorders of sex development (DSD) introduced the concept
of a DSD classification based on karyotype. This consensus
included ‘45,X/46,XY and 45,X/47,XYY (mixed gonadal
dysgenesis, ovotesticular DSD)’ patients in the sex chro-
mosome DSD group [1]. Prior to the consensus statement,
patients with 45,X/46,XY and 45,X/47,XYY mosaicism pre-
senting with genital anomalies would have been diagnosed
with ‘mixed gonadal dysgenesis’ (MGD). However, pub-
lished case series of MGD have included patients with 45,X/
46,XY and 45,X/47,XYY karyotypes, as well as 46,XY [2e4].
The latter group of patients now form part of the 46,XY DSD
group in the consensus classification. The aim of our study
was to review the clinical and gonadal features and early
surgical management of patients with 45,X/46,XY and 45,X/
47,XYY chromosomal mosaicism presenting with genital
anomalies.
Patients and methods
We performed a retrospective study of a cohort of patients
presenting with genital ambiguity and found to have
a 45,X/46,XY or 45,X/47,XYY karyotype, managed in the
Great Ormond Street Hospital for Children between 1988
and 2009. At least one gonadal biopsy or gonadectomy
specimen was available for each patient. Each specimen
was reviewed and re-classified by a specialist paediatric
pathologist (NJS), according to previously published criteria
[5]. Definitions are summarized in Table 1. In all cases
presence of morphological intratubular germ cell neoplasia
was specifically searched for. Data were expressed as
median (range).
Our current practice is for all newly referred patients
with a possible DSD to be initially assessed and investigated
by the endocrine team. Patients are also examined at the
same time by a paediatric urologist and input from a clin-
ical psychologist is provided in most cases [6]. Clinical
findings and investigation results are then discussed atological definitions.
Definition
With or without sec
Normal architecture
Testicular features
Abnormal architectu
or other specific fea
Clear separate area
follicles/oocytes)a multidisciplinary meeting involving endocrinologists,
paediatric urologists, geneticists, adolescent urologists and
gynaecologists, and clinical psychologists. Management
plans and the potential sex of rearing are discussed with the
family at all stages of this process. Patients are typically re-
admitted for an examination under anaesthetic, cystoscopy
and laparoscopy at 2-3 months of age, although in cases
where the findings may have a bearing on the sex of rear-
ing, the procedures may need to be performed more
urgently, in the first few weeks of life. (Early in the series,
laparoscopy was not generally available and hence some of
the patients underwent a laparotomy.) In patients raised
male, intra-abdominal gonads are biopsied and a laparo-
scopic first-stage Fowler-Stephens orchidopexy is per-
formed if indicated. Obvious streak gonads are removed
laparoscopically. In patients raised male with palpable but
undescended gonads, an orchidopexy is performed before 1
year of age. To date, the gonad has not been routinely
biopsied, unless it appeared to be abnormal macroscopi-
cally. Intrascrotal gonads are not normally biopsied.
Hypospadias repair is performed at 1-2 years of age. In
patients raised female, both gonads are typically removed.
Appropriateness and timing of reconstructive surgery in
female patients depends on a number of factors. All gonads
excised or biopsied are routinely submitted for histological
evaluation. Specimens were assessed for standard
morphological features of intratubular germ cell neoplasia
with placental-like alkaline phosphatase (PLAP) immuno-
staining on all cases with seminiferous tubules present,
using standard avidin-biotin procedure on a diagnostic
automated LEICA bond immunostainer (Novocastra PLAP
clone 8A9).Results
A database search yielded a total of 31 patients with genital
anomalies and chromosomal mosaicism, for whom full
clinical and pathological information was available.
Karyotype was 45,X/46,XY in 28 individuals and 45,X/
47,XYY in 3 individuals. All children were referred to theondary non-specific cryptorchid-associated changes
with typical ovarian stroma and oocytes
with abnormal architecture and ovarian-type gonadal stroma
re and ovarian-type stroma only, with absence of germ cells
tures
s of definite testicular and ovarian tissue (including ovarian
Chromosomal mosaicism with genital anomalies 141endocrine team with genital anomalies shortly after birth,
except for 4 patients, of whom 3 were referred from other
centres within the first year of life (Australia, Qatar, Scot-
land) and one was diagnosed at 4 years of age following
a referral for hypospadias repair. Only 1 set of parents were
known to be consanguineous. None of the cases included in
this series were prenatally diagnosed, although in two cases
there was a prenatal suspicion of Turner syndrome. Median
gestational age at birth was 39 (27e41) weeks.
Nineteen patients were raised male (n Z 18 45,X/46,XY
and n Z 1 45,X/47,XYY). Their clinical features at
presentation are summarized in Table 2A. Median age at
initial surgical intervention in this group of patients was
19.5 (0.5e72) months, and the interventions were as
follows: laparoscopy/laparotomy (n Z 11), gonadectomy
(n Z 11, including 1 bilateral gonadectomy), staged hypo-
spadias repair (nZ 18), orchidopexy (nZ 9). The utriculus
was excised in 2 patients, and 1 patient had a vaginectomy.
Median age at gonadal biopsy or gonadectomy was 6.5
(1e27) months. Twelve patients were raised female
(n Z 10 45,X/46,XY and n Z 2 45,X/47,XYY), and their
clinical features at presentation are summarized in Table
2B. Median age at initial surgical intervention was 12.0
(1e180) months, and the interventions were as follows:
laparoscopy/laparotomy (nZ 10), bilateral gonadectomies
(n Z 12), genitoplasty (n Z 7) and clitoral reduction
(n Z 5).
The histology of 46 gonads was available from patients
who had undergone a gonadectomy or gonadal biopsy.
Median age at gonadal biopsy or gonadectomy was 9.5
(1e180) months. Gonadal histology is summarized in Table
3 and illustrated in Fig. 1AeD. Of the total cohort
(n Z 31), 7 patients (23%) had bilateral palpable gonads
(inguinal or scrotal). Seventeen patients (55%) had
a palpable gonad on one side, and an impalpable gonad on
the contralateral side. Of the palpable gonads, 16 (52%)
were in an inguinal location, 10 (32%) were scrotal, and in 5
(16%) the exact location was unknown. Histology of the
palpable gonad was only available for those gonads that
were biopsied or removed. Of note, 3 gonads palpable in
the inguinal region were found to be streak gonads (nZ 2)
and an unusual dysgenetic gonad (Fig. 1A). The latter gonad
exhibited distinct, polar areas of testicular tissue and
ovarian-type stroma with cysts reminiscent of follicular
cysts but no oocytes or normal ovarian tissue. This
appearance differed from the structure of the other dys-
genetic gonads in our series, where the ovarian-type stromaTable 2 A and B. Clinical characteristics of patients with 45,X/
A) Clinical features of patients raised male (n Z 19)
Phallus Penoscrotal/perineal
hypospadias (n Z 18)
Nor
me
Scrotum Normal scrotum (n Z 13) Bifi
Gonads Palpable gonads bilaterally (n Z 5) One
Mu¨llerian structures Utriculus (n Z 11) Hem
B) Clinical features of patients raised female (n Z 12)
Phallus Clitoromegaly (n Z 12)
Gonads Palpable gonads bilaterally (n Z 2) One
Mu¨llerian structures Utriculus (n Z 7) Hemwas at the periphery of the gonad surrounding the testic-
ular tissue (Fig. 1B). The histology of the scrotal gonad was
available in 3 out of 10 cases, of which only 1 was a histo-
logically unremarkable testis, the remaining 2 being a dys-
genetic testis and a streak gonad (Fig. 1C). The normal
testis was removed from a patient reared female, whereas
the dysgenetic testis and streak gonad were from patients
reared male, and were initially palpably indistinguishable
from a normal testicle. Hence, they were not biopsied in
infancy. However, both gonads ‘ascended’ later in child-
hood, were subsequently noted to be abnormal at orchid-
opexy, and were biopsied. Overall, histology of the
palpable gonad was known in 18 cases, of which 5 (28%)
were histologically unremarkable testes.
Seven patients (23%) presented with bilateral impal-
pable gonads. In 2 cases, an intra-abdominal gonad could
not be found suggesting agenesis or regression. The
majority of intra-abdominal gonads identified in the entire
series were either dysplastic testes (38%) or streaks (45%).
Only 1 intra-abdominal testis (3%) was histologically unre-
markable. Only 1 patient had a gonadectomy after 30
months of age. This patient (45,X/47,XYY raised female)
had emigrated to the Middle-East soon after diagnosis in
infancy, and re-presented with a pair of intra-abdominal
gonads still in situ at 15 years of age. Bilateral gonadectomy
was performed, and histology revealed bilateral dysgenetic
testes containing numerous morphologically normal but
PLAP-positive cells (suggestive of dysmaturity or early
intratubular germ cell neoplasia unclassified; Fig. 1D). The
patient, who was raised female, also had features of Turner
syndrome. There were no cases with morphological
features of intratubular germ cell neoplasia despite the 1
case with immunohistochemical staining features described
above, and no cases of gonadoblastoma or frank
malignancy.
Fifteen patients (48%) were found to have other anom-
alies. The patient with 45,X/47,XYY karyotype and bilateral
PLAP-positive gonads also had total anomalous pulmonary
venous drainage, a high arched palate, skin pigmentation,
long fingers, deafness, and reduced vision. Four further
patients had cardiovascular anomalies (ventricular septal
defect, aortic stenosis, aortic regurgitation and patent
ductus arteriosus with patent foramen ovale), giving a 16%
incidence of documented cardiovascular anomalies in this
series. Five patients (16%) were found to have renal
abnormalities including a horseshoe kidney in 3 patients,
and 1 duplex and 1 multicystic dysplastic kidney. One of the46,XY and 45,X/47,XYY presenting with genital anomalies.
mally placed terminal
atus (n Z 1)
d scrotum (n Z 3) Hemiscrotum (n Z 3)
palpable gonad (n Z 13) No palpable gonads (n Z 1)
i-utriculus (n Z 1) No Mu¨llerian structures (n Z 7)
palpable gonad (n Z 5) No palpable gonads (n Z 5)
i-utriculus (n Z 3) No Mu¨llerian structures (n Z 2)
Table 3 Summary of gonadal histology.
Palpable (n Z 31) Impalpable (n Z 31)
Inguinal (n Z 16)
5 not biopsied
4 dysgenetic testes
3 normal testes
2 streak gonads
1 immature testis
1 ovotestis-like gonad
Scrotal (n Z 10)
7 not biopsied
1 dysgenetic testisa
1 normal testis
1 streak gonada
Unknown (n Z 5)
1 not biopsied
2 dysgenetic testes
1 immature testis
1 normal testis
Absent (n Z 2) Intra-abdominal (n Z 29)
13 streak gonads
11 dysgenetic testes (2 PLAP-positiveb)
3 immature testes
1 normal testis
1 unknown
a Gonads initially scrotal but ‘ascended’ and were biopsied at orchidopexy.
b Both placental-like alkaline phosphatase positive testes were found in the same patient.
142 M.K. Farrugia et al.patients with a horseshoe kidney also had bilateral colo-
bomas and reduced vision. Only 1 patient had both renal
and cardiac anomalies. Two patients were noted to have
adrenocortical rests on their testes, of whom 1 had clinical
adrenocortical insufficiency. Four patients (13%) were
noted to have significantly short stature and curved
fingernails, compatible with a Turner phenotype. Two
patients had gastrointestinal problems (pyloric stenosis and
coeliac disease).
Discussion
45X/46,XY and 45,X/47,XYY chromosomal mosaicism is
rare, with an incidence of 1.7/10,000 pregnancies. Only
5e10% of individuals with a prenatally diagnosed mosaicFigure 1 A: An unusual dysgenetic gonad showing distinct area
ovarian follicles or germ cells. B: Dysgenetic testis showing disorga
stroma (O). C: Streak gonad lacking germ cells. D: Placental-like alk
suggestive of delayed maturation or intratubular germ cell neoplakaryotype of 45,X/46,XY will have ambiguous genitalia at
birth, with the remainder being phenotypic male [7]. Chang
et al. reported a series of 92 prenatally diagnosed cases of
chromosomal mosaicism, including 88 45,X/46,XY and 4
45,X/47,XYY mosaics, of whom only 4 (5%) were noted to
have genital anomalies. There was no relation between the
percent mosaicism (the number of 45,X cells relative to the
total number of cells) and the presence or degree of
abnormalities. Long-term follow-up revealed that mental
status and stature were normal, except for 1 male whose
height was below the fifth percentile [7]. There appears to
be a phenotypic difference between prenatally and post-
natally diagnosed cases of 45,X/46,XY or 45,X/47,XYY
mosaicism, the latter being more likely to present with
genital anomalies [8,9]. Although the presentation of 45,X/s of ovarian-type stroma (O) and testicular (T) tissue, but no
nized testicular tissue (T) surrounded by atypical ovarian-type
aline phosphatase immunostaining, seen as brown-staining (P),
sia unclassified.
Chromosomal mosaicism with genital anomalies 14346,XY mosaicism with genital anomalies only represents
a small proportion of cases with this karyotype, these are
the most challenging cases to manage. The genital anom-
alies reported to date range from phenotypic males with
cryptorchidism or hypospadias to phenotypic females with
gonadal dysgenesis [10]. The more typical combination of
a unilateral testis, contralateral streak gonad and persis-
tent Mu¨llerian derivatives was previously called ‘mixed
gonadal dysgenesis’ (MGD), a common diagnosis given to
45,X/46,XY mosaic infants with genital anomalies [11,12].
However, using this term as a diagnosis can be confusing, as
most published series of MGD have included patients with
46,XY as well as mosaic karyotypes [2e5,14]. The consensus
statement has since re-classified patients with 45,X/46,XY
mosaicism and genital anomalies (sex chromosome DSD)
and 46,XY patients with ‘partial gonadal dysgenesis’ (46,XY
DSD) into two separate categories [1].
Our series revealed that 45,X/46,XY mosaicism and its
variants may be associated with other anomalies, namely
cardiac (16%) and renal (16%). Only 4 patients (13%),
however, had other Turner features such as short stature
and curved fingernails. Although this combination of
features is typical of Turner syndrome (most commonly 45,X
or 45,X/46,XX mosaic) [13], there are only limited reports
of their association with 45,X/46,XY mosaicism [8,14].
Wallace and Levin also documented a high incidence of
cardiac anomalies in 45,X/46,XY mosaics, including
bicuspid aortic valve, retro-oesophageal aortic arch, aber-
rant left subclavian artery, coarctation and dissection [14].
Cardiac and renal imaging is therefore recommended in
these infants at diagnosis.
Sex assignment may be challenging, and the surgical
approach has evolved over the years. Papers published
only 20e30 years ago recommended early gonadectomy
and a female sex assignment [2e4], an approach which has
recently changed, with increased emphasis on a conserva-
tive approach and the delay of irreversible surgery until
adulthood. Several factors are involved in decision making
regarding sex assignment, including long-term likely
gender identity; urological and sexual function and genital
appearance; the possible need for endocrine replacement
therapy to induce puberty and throughout adult life; and
any capacity for future fertility. All these factors are in
addition to the malignancy risk associated with the
condition, which has made gonadal management, partic-
ularly in patients raised male, increasingly challenging.
The fact that the prevalence of malignant germ cell
tumours is increased in patients with DSD containing Y
chromosome material in their karyotype is well docu-
mented, and is probably related to the presence and
aberrant expression of the testis-specific protein on Y
(TSPY) gene, proximal on Yp [15e20]. The ectopic position
of the dysgenetic testis adds to this risk because the
prevalence of germ cell tumours in simple cryptorchidism
is estimated at 4e10 times the normal prevalence of 6e11
per 100,000 [21]. Cools et al. reported that in series of
patients with MGD the overall prevalence of germ cell
tumours is 18 out of 119 patients (15%) [18]. The same
group went on to specifically look at tumour risk in relation
to clinical characteristics, in a series of 48 patients with
45,X/46,XY mosaicism [22]. It is interesting to note that
the authors also describe the occurrence of 1 intra-abdominal gonad containing marked ovarian differentia-
tion with ovarian follicles in their series, which is similar to
the finding in our study. An inguinal streak gonad was also
encountered, although all scrotal gonads were found to be
testes. Fifteen gonads, including 4 with in-situ neoplastic
lesions, in 12 different patients, were found to have pre-
malignant characteristics. Tumour risk was significantly
reflected by clinical phenotype, and revealed to be very
high (52%) in patients with an ambiguous phenotype.
Inguinal gonads displayed (pre)malignant characteristics
more frequently compared with scrotal or abdominal
gonads; however the difference was not statistically
significant. Conversely, the phenotypically female patients
were found to have a lower tumour risk, which the authors
attribute to the fact that these patients were more likely
to have streak or ‘vanished’ gonads. This finding is of
course in contrast to that in our series, whereby the only
pre-malignant gonads were found in a phenotypically
female patient with intra-abdominal dysgenetic testes.
The long-term potential for hormone production and
fertility in mosaic individuals is not clear in the literature.
Three of 27 patients in the Telvi series went through
a normal puberty even after their unilateral streak gonads
were removed [8]. Robboy et al. reported that even when
MGD gonads in 45,X/46,XY individuals were shown to be rich
in germ cells when biopsied in infancy, gonadectomy 6e13
years later demonstrated the same gonads to be densely
hyalinized and fibrous [4]. There are also several reports of
phenotypic males with 45,X/46,XY mosaicism presenting to
infertility clinics and being found to be azoospermic
[23e25].
Our study is limited by its retrospective nature and small
patient numbers. The underlying genetics and gonadal
pathology in this rare condition are currently being eluci-
dated in greater detail than ever before [26,27], utilizing
immunohistochemical techniques that were not previously
available. Our gonadal specimens were not tested for
aberrant TSPY expression or other genetic markers, such as
the octamer binding transcription factor 3/4 (OCT3/4) and
c-KIT ligand stem cell factor, which have been successfully
used in recent studies [22]. Cools et al. hypothesized that
the combination of prolonged OCT3/4 expression and TSPY
expression in the germ cells of DSD patients is of pathoge-
netic relevance for the development of gonadoblastoma in
these patients [28]. Widespread availability of these tech-
niques may become of great value when assessing the
tumour risk of dysgenetic testes biopsied at orchidopexy or
post puberty, as advised by the consensus statement [1],
and we feel that this would be the best way forward when
managing patients raised male, whose gonads are
preserved. In addition, since our centre is a paediatric one,
we do not currently know the adult outcome of some of our
post-pubertal patients, whose care has been transferred to
an adolescent uro-gynaecology centre. We therefore aim to
trace these patients and study their endocrine and pubertal
outcome in a separate study.
Conclusion
The anatomy and gonadal histology of 45,X/46,XY and 45,X/
47,XYY individuals with genital abnormalities is more
complex than previously thought, and our study highlights
144 M.K. Farrugia et al.the importance of detailed anatomical and histological
assessment at an early age. In patients raised male, where
dysgenetic testes are retained, biopsy at orchidopexy and
post puberty with appropriate immuo-histochemical stain-
ing is warranted to identify patients at increased risk of
malignancy.
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